Cargando…
CCR7 Receptor Expression in Mono-MAC-1 Cells: Modulation by Liver X Receptor α Activation and Prostaglandin E(2)
Cell migration via chemokine receptor CCR7 expression is an essential function of the immune system. We previously showed that prostaglandin E(2) (PGE(2)), an important immunomodulatory molecule, increases CCR7 expression and function in monocytes. Here, we explore the role of the liver X receptor α...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684868/ https://www.ncbi.nlm.nih.gov/pubmed/26770865 http://dx.doi.org/10.1155/2015/201571 |
_version_ | 1782406221622411264 |
---|---|
author | Tanné, Bérengère Bernier, Stéphane Dumais, Nancy |
author_facet | Tanné, Bérengère Bernier, Stéphane Dumais, Nancy |
author_sort | Tanné, Bérengère |
collection | PubMed |
description | Cell migration via chemokine receptor CCR7 expression is an essential function of the immune system. We previously showed that prostaglandin E(2) (PGE(2)), an important immunomodulatory molecule, increases CCR7 expression and function in monocytes. Here, we explore the role of the liver X receptor α (LXRα) activation on CCR7 expression in Mono-Mac-1 (MM-1) cells in the presence of PGE(2). To do this, MM-1 cells were stimulated with the LXRα synthetic agonist T0901317 in the presence or absence of PGE(2). CCR7 mRNA transcription was measured using quantitative RT-PCR and protein expression was examined using flow cytometry. CCR7 function was analyzed using migration assays in response to CCL19/CCL21, which are natural ligands for CCR7. Our results show that agonist-mediated activation of LXRα in the presence of PGE(2) increases CCR7 mRNA transcription and MM-1 cell migratory capacity in response to CCL19/21. In addition, our results demonstrate that engagement of the E-prostanoids 2 and 4 (EP(2)/EP(4)) receptors present on MM-1 cells is responsible for the observed increase in CCR7 mRNA expression and function during LXRα activation. Examination of monocyte migration in response to lipid derivatives such as PGE(2) and oxysterols that are produced at sites of chronic inflammation would contribute to understanding the excessive monocyte migration that characterizes atherosclerosis. |
format | Online Article Text |
id | pubmed-4684868 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-46848682016-01-14 CCR7 Receptor Expression in Mono-MAC-1 Cells: Modulation by Liver X Receptor α Activation and Prostaglandin E(2) Tanné, Bérengère Bernier, Stéphane Dumais, Nancy Int J Inflam Research Article Cell migration via chemokine receptor CCR7 expression is an essential function of the immune system. We previously showed that prostaglandin E(2) (PGE(2)), an important immunomodulatory molecule, increases CCR7 expression and function in monocytes. Here, we explore the role of the liver X receptor α (LXRα) activation on CCR7 expression in Mono-Mac-1 (MM-1) cells in the presence of PGE(2). To do this, MM-1 cells were stimulated with the LXRα synthetic agonist T0901317 in the presence or absence of PGE(2). CCR7 mRNA transcription was measured using quantitative RT-PCR and protein expression was examined using flow cytometry. CCR7 function was analyzed using migration assays in response to CCL19/CCL21, which are natural ligands for CCR7. Our results show that agonist-mediated activation of LXRα in the presence of PGE(2) increases CCR7 mRNA transcription and MM-1 cell migratory capacity in response to CCL19/21. In addition, our results demonstrate that engagement of the E-prostanoids 2 and 4 (EP(2)/EP(4)) receptors present on MM-1 cells is responsible for the observed increase in CCR7 mRNA expression and function during LXRα activation. Examination of monocyte migration in response to lipid derivatives such as PGE(2) and oxysterols that are produced at sites of chronic inflammation would contribute to understanding the excessive monocyte migration that characterizes atherosclerosis. Hindawi Publishing Corporation 2015 2015-12-06 /pmc/articles/PMC4684868/ /pubmed/26770865 http://dx.doi.org/10.1155/2015/201571 Text en Copyright © 2015 Bérengère Tanné et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Tanné, Bérengère Bernier, Stéphane Dumais, Nancy CCR7 Receptor Expression in Mono-MAC-1 Cells: Modulation by Liver X Receptor α Activation and Prostaglandin E(2) |
title | CCR7 Receptor Expression in Mono-MAC-1 Cells: Modulation by Liver X Receptor α Activation and Prostaglandin E(2)
|
title_full | CCR7 Receptor Expression in Mono-MAC-1 Cells: Modulation by Liver X Receptor α Activation and Prostaglandin E(2)
|
title_fullStr | CCR7 Receptor Expression in Mono-MAC-1 Cells: Modulation by Liver X Receptor α Activation and Prostaglandin E(2)
|
title_full_unstemmed | CCR7 Receptor Expression in Mono-MAC-1 Cells: Modulation by Liver X Receptor α Activation and Prostaglandin E(2)
|
title_short | CCR7 Receptor Expression in Mono-MAC-1 Cells: Modulation by Liver X Receptor α Activation and Prostaglandin E(2)
|
title_sort | ccr7 receptor expression in mono-mac-1 cells: modulation by liver x receptor α activation and prostaglandin e(2) |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684868/ https://www.ncbi.nlm.nih.gov/pubmed/26770865 http://dx.doi.org/10.1155/2015/201571 |
work_keys_str_mv | AT tanneberengere ccr7receptorexpressioninmonomac1cellsmodulationbyliverxreceptoraactivationandprostaglandine2 AT bernierstephane ccr7receptorexpressioninmonomac1cellsmodulationbyliverxreceptoraactivationandprostaglandine2 AT dumaisnancy ccr7receptorexpressioninmonomac1cellsmodulationbyliverxreceptoraactivationandprostaglandine2 |